Demand for FDA Action Amid Shuffle Sarah Owermohle, Zachary Brennan and David Lim | Politico “The president’s executive order for CMS to finalize a rule eliminating rebates that drugmakers pay to pharmacy benefit managers had one big caveat — the rule cannot...
US Chamber of Commerce Launches Campaign to Defend Employer-Sponsored Health Insurance Steve Salkin | BenefitsPro “The Chamber of Commerce cites a new report from economic policy consulting firm Matrix Global Advisors on the negative economic effects of expanded...
New MGA Report on the Negative Economic Effects of Medicare Buy-In and Public Option Proposals Matrix Global Advisors (MGA) today released a new report, “The Negative Economic Effects of Medicare Buy-In and Public Option Proposals,” by MGA founder and CEO Alex Brill....
Shared Savings Models Could Yield Part B Savings Skylar Jeremias | The Center for Biosimilars “The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in...
New MGA Report on a Medicare Shared Savings Demonstration for Biosimilars Matrix Global Advisors (MGA) today released a new report, “Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition,” by MGA...
